409 related articles for article (PubMed ID: 15567426)
21. Learning impairment by Δ(9)-tetrahydrocannabinol in adolescence is attributable to deficits in chunking.
Steel RW; Miller JH; Sim DA; Day DJ
Behav Pharmacol; 2011 Dec; 22(8):837-46. PubMed ID: 22067480
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of cholinergic function in spatial and procedural learning in rats.
von Linstow Roloff E; Harbaran D; Micheau J; Platt B; Riedel G
Neuroscience; 2007 May; 146(3):875-89. PubMed ID: 17418958
[TBL] [Abstract][Full Text] [Related]
23. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
Eichler M; Spinedi L; Unfer-Grauwiler S; Bodmer M; Surber C; Luedi M; Drewe J
Planta Med; 2012 May; 78(7):686-91. PubMed ID: 22411724
[TBL] [Abstract][Full Text] [Related]
24. Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.
Stadelmann AM; Juckel G; Arning L; Gallinat J; Epplen JT; Roser P
Neurosci Lett; 2011 May; 496(1):60-4. PubMed ID: 21513772
[TBL] [Abstract][Full Text] [Related]
25. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
Hillard CJ; Harris RA; Bloom AS
J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
[TBL] [Abstract][Full Text] [Related]
26. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Moldzio R; Pacher T; Krewenka C; Kranner B; Novak J; Duvigneau JC; Rausch WD
Phytomedicine; 2012 Jun; 19(8-9):819-24. PubMed ID: 22571976
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.
Sagredo O; Pazos MR; Satta V; Ramos JA; Pertwee RG; Fernández-Ruiz J
J Neurosci Res; 2011 Sep; 89(9):1509-18. PubMed ID: 21674569
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
[TBL] [Abstract][Full Text] [Related]
29. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat.
List A; Nazar B; Nyquist S; Harclerode J
Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of cannabinoids in the elevated plus maze.
Onaivi ES; Green MR; Martin BR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1002-9. PubMed ID: 2162942
[TBL] [Abstract][Full Text] [Related]
31. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
Zuardi AW; Karniol IG
Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of delta9-THC on learning in adolescent and adult rats.
Cha YM; White AM; Kuhn CM; Wilson WA; Swartzwelder HS
Pharmacol Biochem Behav; 2006 Mar; 83(3):448-55. PubMed ID: 16631921
[TBL] [Abstract][Full Text] [Related]
33. Delta(9)-THC administered into the medial prefrontal cortex disrupts the spatial working memory.
Silva de Melo LC; Cruz AP; Rios Valentim SJ; Marinho AR; Mendonça JB; Nakamura-Palacios EM
Psychopharmacology (Berl); 2005 Nov; 183(1):54-64. PubMed ID: 16163518
[TBL] [Abstract][Full Text] [Related]
34. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Taffe MA; Creehan KM; Vandewater SA
Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
[TBL] [Abstract][Full Text] [Related]
35. Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex.
Rodrigues LC; Conti CL; Nakamura-Palacios EM
Brain Res; 2011 Mar; 1382():230-7. PubMed ID: 21281616
[TBL] [Abstract][Full Text] [Related]
36. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
[TBL] [Abstract][Full Text] [Related]
37. Kamikihi-to, a Kampo medicine, ameliorates impairment of spatial memory in rats.
Egashira N; Manome N; Kurauchi K; Matsumoto Y; Iwasaki K; Mishima K; Shoyama Y; Fujiwara M
Phytother Res; 2007 Feb; 21(2):126-9. PubMed ID: 17117451
[TBL] [Abstract][Full Text] [Related]
38. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594
[TBL] [Abstract][Full Text] [Related]
39. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
40. Δ
Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]